Leadership
Giulio F. Draetta, M.D., Ph.D.
Chief Scientific Officer
Sr. Vice President & Head, Therapeutics Discovery
Philip Jones, Ph.D.
Vice President, Therapeutics Discovery
Head of Drug Discovery
Jason Bock, Ph.D.
Vice President, Therapeutics Discovery
Head of Biologics Product Development
Platform Leadership
The Therapeutics Discovery division supports six research platforms.
Biologics Development
-
Jason Bock, Ph.D.
Vice President, Therapeutics Discovery
ECLIPSE
-
Jeffrey Molldrem, M.D.
Professor, Stem Cell Transplantation and Cellular Therapy
Institute for Applied Cancer Science (IACS)
-
Philip Jones, Ph.D.
Head of Drug Discovery
Neurodegeneration Consortium (NDC)
-
Jim Ray, Ph.D.
Head, Neurodegeneration Research
TRACTION
-
Tim Heffernan, Ph.D.
Executive Director, Oncology Research
-
Joseph Marzalek, Ph.D.
Co-leader, TRACTION
Give Now
Your gift will help make a tremendous difference.
Research Areas
Find out about the four types of research taking place at MD Anderson.
Subscribe
Get the latest information on our cancer breakthroughs.